Sinopharm Group Co 주식 주식분석 | 주식가격 | 뉴스 | 1099.HK | CNE100000FN7 | A0N99U

날짜	Sinopharm Group Co 주식 가격
	17.99 undefined
	17.95 undefined
	17.71 undefined
	17.87 undefined
	18.36 undefined
	18.62 undefined
	18.31 undefined
	18.37 undefined
	18.81 undefined
	18.56 undefined
	18.50 undefined
	18.37 undefined
	17.87 undefined
	18.16 undefined
	18.08 undefined
	18.45 undefined
	18.99 undefined
	18.54 undefined
	19.08 undefined
	21.28 undefined

날짜	Sinopharm Group Co 매출	Sinopharm Group Co EBIT	Sinopharm Group Co 이익
2028e	753.31 조. undefined	31.48 조. undefined	3.91 조. undefined
2027e	729.68 조. undefined	29.39 조. undefined	3.65 조. undefined
2026e	695.84 조. undefined	24.62 조. undefined	4.33 조. undefined
2025e	653 조. undefined	22.89 조. undefined	4 조. undefined
2024e	613.65 조. undefined	21.29 조. undefined	3.68 조. undefined
2023	596.57 조. undefined	22.28 조. undefined	9.05 조. undefined
2022	552.15 조. undefined	22.54 조. undefined	8.53 조. undefined
2021	521.05 조. undefined	20.84 조. undefined	7.76 조. undefined
2020	456.41 조. undefined	19.03 조. undefined	7.19 조. undefined
2019	425.27 조. undefined	18.09 조. undefined	6.25 조. undefined
2018	344.53 조. undefined	15.75 조. undefined	5.84 조. undefined
2017	308.35 조. undefined	13.14 조. undefined	5.58 조. undefined
2016	258.39 조. undefined	10.21 조. undefined	4.65 조. undefined
2015	228.67 조. undefined	9.23 조. undefined	3.77 조. undefined
2014	200.13 조. undefined	7.86 조. undefined	2.87 조. undefined
2013	166.87 조. undefined	6.1 조. undefined	2.25 조. undefined
2012	135.79 조. undefined	4.86 조. undefined	1.97 조. undefined
2011	102.23 조. undefined	3.64 조. undefined	1.56 조. undefined
2010	69.23 조. undefined	2.41 조. undefined	1.21 조. undefined
2009	47.05 조. undefined	1.55 조. undefined	846 백만 undefined
2008	38.19 조. undefined	1.17 조. undefined	586 백만 undefined
2007	31.11 조. undefined	789 백만 undefined	381 백만 undefined
2006	23.74 조. undefined	480 백만 undefined	101 백만 undefined

	매출	EBIT	이익
2006	23.74 조. CNY	480 백만 CNY	101 백만 CNY
2007	31.11 조. CNY	789 백만 CNY	381 백만 CNY
2008	38.19 조. CNY	1.17 조. CNY	586 백만 CNY
2009	47.05 조. CNY	1.55 조. CNY	846 백만 CNY
2010	69.23 조. CNY	2.41 조. CNY	1.21 조. CNY
2011	102.23 조. CNY	3.64 조. CNY	1.56 조. CNY
2012	135.79 조. CNY	4.86 조. CNY	1.97 조. CNY
2013	166.87 조. CNY	6.1 조. CNY	2.25 조. CNY
2014	200.13 조. CNY	7.86 조. CNY	2.87 조. CNY
2015	228.67 조. CNY	9.23 조. CNY	3.77 조. CNY
2016	258.39 조. CNY	10.21 조. CNY	4.65 조. CNY
2017	308.35 조. CNY	13.14 조. CNY	5.58 조. CNY
2018	344.53 조. CNY	15.75 조. CNY	5.84 조. CNY
2019	425.27 조. CNY	18.09 조. CNY	6.25 조. CNY
2020	456.41 조. CNY	19.03 조. CNY	7.19 조. CNY
2021	521.05 조. CNY	20.84 조. CNY	7.76 조. CNY
2022	552.15 조. CNY	22.54 조. CNY	8.53 조. CNY
2023	596.57 조. CNY	22.28 조. CNY	9.05 조. CNY
2024e	613.65 조. CNY	21.29 조. CNY	3.68 조. CNY
2025e	653 조. CNY	22.89 조. CNY	4 조. CNY
2026e	695.84 조. CNY	24.62 조. CNY	4.33 조. CNY
2027e	729.68 조. CNY	29.39 조. CNY	3.65 조. CNY
2028e	753.31 조. CNY	31.48 조. CNY	3.91 조. CNY

2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

1.84	1.96	1.71	6.62	7.48	13.1	9.72	14	15.23	19.97	25.58	32.24	40.34	39.19	50.22	43.54	55.33	63.81
4.55	5.58	7.25	9.61	16.19	24.12	34.17	46.9	61.82	58.35	59.76	68.56	96.61	109.5	134.4	159.41	153.28	165.97
0.52	0.8	0.79	3.96	1.85	3.26	3.79	5.77	5.25	8.25	13.02	16.36	13.75	17.07	15.04	16.86	22.45	23.83
2.31	2.9	3.56	4.63	8.46	13.88	15.96	18.83	20.31	22.55	25.76	30.27	35.39	42.59	47.09	51.5	60.93	60.03
0.18	0.72	0.37	0.47	0.88	1.87	2.38	4.22	7.66	8.78	8.64	15.34	18.56	21.65	20.86	19.61	27.42	23.2
9.4	11.96	13.68	25.29	34.86	56.23	66.02	89.71	110.27	117.9	132.76	162.77	204.65	230	267.61	290.92	319.41	336.84
1.09	1.19	1.26	1.45	3.33	4.43	5.38	6.31	7.1	7.64	6.75	9.01	11.03	18.06	18.9	19.41	19.65	19.9
0.33	0.39	0.42	0.48	0.69	0.88	1.07	1.17	1.64	1.85	4.2	6.91	7.65	8.52	9.11	9.77	10.38	11.05
0	0	0	0	0	0	0	0	0	1.55	3.79	0.01	0.01	0.02	0.03	0.01	0.01	0.01
0.15	0.15	0.12	0.2	0.82	1.65	2.15	2.14	2.62	2.72	2.45	2.55	2.58	3.32	3.44	3.19	3.02	3.01
0.03	0.03	0.03	0.12	0.69	2.88	3.4	3.47	3.72	4	3.83	4.7	4.9	5.66	7.29	7.2	7.16	7.19
0.6	0.57	0.61	0.73	1.62	1.55	1.83	2.66	3.29	3.76	3.93	4.74	4.96	4.3	4.86	4.91	5.17	5.41
2.19	2.33	2.43	2.99	7.15	11.4	13.83	15.74	18.38	21.53	24.95	27.92	31.12	39.89	43.63	44.49	45.37	46.56
11.59	14.29	16.12	28.28	42.02	67.63	79.85	105.45	128.66	139.43	157.71	190.69	235.77	269.89	311.24	335.41	364.78	383.39

1.64	1.64	1.64	2.27	2.27	2.4	2.4	2.57	2.77	2.77	2.77	2.77	2.97	2.97	3.12	3.12	3.12	3.12
-0.01	-0.01	-0.01	-0.01	-0.21	-0.23	10.83	13.89	18.08	18.08	18.08	18.08	21.22	21.22	24.64	24.64	24.64	0
0.13	0.05	0.63	8.64	9.64	13.49	3.84	5.35	6.52	9.23	10.94	17.44	18.62	23.21	28.57	34.11	40.29	71.47
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	33.38	37.61	0
5	12	7	16	16	10	10	12	16.69	33.99	30.64	16.59	12.07	15.65	22.66	20.49	17.22	0
1.76	1.68	2.26	10.91	11.71	15.68	17.08	21.82	27.38	30.11	31.81	38.3	42.82	47.42	56.36	95.27	105.68	74.59
5.63	7.21	9.05	12.14	19.83	27.05	34.69	44.19	54.72	59.56	66.75	72.49	83.68	100.33	112.63	128.43	137.09	146.63
0.43	0.45	0.43	0.46	0.6	0.93	1.13	1.58	1.69	2.13	2.65	4.06	4.48	5.4	7.76	8.35	9.57	8.83
0.51	1.76	0.89	0.87	1.98	3.64	3.4	4.06	4.37	5.57	7.98	16.39	21.83	29.02	27.22	25.82	33.67	29.5
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.7	1.52	1.5	1.28	3.34	8.67	10.89	21.01	25.23	28.36	22.36	31.65	50.09	43.67	56.37	56.7	54.63	56.53
8.27	10.95	11.88	14.75	25.75	40.29	50.11	70.84	86.02	95.62	99.74	124.58	160.07	178.42	203.98	219.31	234.96	241.49
0.18	0.16	0.13	0.05	0.09	5.18	5.19	4.13	4.22	0.76	11.2	5.59	5.02	11.47	12.16	11.67	14.96	17.25
0.07	0.07	0.06	0.1	0.27	0.52	0.59	0.6	0.63	0.69	0.6	0.85	0.86	1.1	1.11	1.02	0.94	0.79
0.48	0.5	0.63	0.87	1.19	1.25	1.22	1.27	1.49	1.48	1.64	1.72	1.54	1.95	4.04	3.76	3.85	3.54
0.73	0.72	0.83	1.02	1.54	6.95	7	6	6.35	2.93	13.44	8.16	7.42	14.52	17.31	16.45	19.74	21.59
9	11.67	12.71	15.77	27.3	47.24	57.1	76.84	92.37	98.55	113.18	132.75	167.5	192.95	221.29	235.76	254.71	263.08
10.76	13.35	14.97	26.68	39.01	62.92	74.18	98.66	119.75	128.66	144.99	171.05	210.32	240.37	277.65	331.03	360.39	337.66

2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0.36	0.82	1.08	1.57	2.4	3.13	4.01	4.62	5.93	7.47	8.92	11.23	12.21	13.76	15.6	17	18.56
0.13	0.14	0.17	0.2	0.3	0.46	0.57	0.68	0.84	1.01	1.07	1.24	1.39	3.11	3.6	3.92	4.17
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.05	-0.54	-0.69	-0.74	-1.54	-3.16	-1.58	-2.16	-3.43	3.01	-2.17	-11.19	-13.43	-2.98	-12.38	-16.18	-6.47
0.19	0.02	0.1	-0.02	0.05	0.59	1.02	1.8	2.22	1.93	1.44	1.93	3.48	4.88	4.33	4.56	4.71
0.1	0.14	0.24	0.21	0.31	0.75	1.3	1.6	2.2	1.97	1.99	2.43	4.05	5.18	4.64	4.58	4.78
0.15	0.23	0.3	0.35	0.51	0.83	0.97	1.08	1.39	1.79	2.05	2.73	2.77	3.44	3.66	4.07	4.4
0.64	0.44	0.65	1.01	1.2	1.02	4.02	4.94	5.56	13.41	9.26	3.21	3.65	18.78	11.15	9.31	20.96
-192	-238	-277	-344	-1,444	-1,027	-1,352	-1,211	-1,694	-1,233	-1,363	-2,270	-3,404	-2,548	-2,087	-2,255	-2,417
-271	-14	-148	-3,116	-1,831	-2,831	-2,209	-4,066	-4,357	-1,643	-1,606	-3,159	-5,907	-6,795	-2,202	-1,266	-3,589
-79	224	129	-2,772	-387	-1,804	-856	-2,856	-2,663	-409	-242	-889	-2,503	-4,247	-115	988	-1,172
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.04	0.39	-0.72	-0.37	1.16	6.14	-2.7	2.75	-1.18	-3.69	2.33	7.75	14.28	-5.47	6.44	-6.54	2.92
0.31	0	0	8.85	0	2.84	0	3.23	0	0	0	-0.2	0	0.05	3.6	0	0
0.12	-0.31	-0.75	7.01	0.54	7.43	-5.18	3.41	0.02	-7.16	-2.03	3.98	10.32	-13.08	2.03	-14.69	-5.69
-130	-695	99	-391	-603	-1,184	-2,023	-1,919	-2,517	-2,608	-3,217	-2,192	-2,390	-5,913	-6,145	-5,997	-6,273
-101	0	-128	-1,074	-23	-363	-456	-642	-667	-857	-1,134	-1,383	-1,577	-1,753	-1,865	-2,153	-2,340
0.49	0.12	-0.24	4.91	-0.09	5.62	-3.37	4.2	1.23	4.66	5.61	4.04	8.06	-1.11	10.99	-6.65	11.69
446	203	377	668	-241	-8	2,665	3,730	3,866.39	12,178.55	7,894.13	938.2	249.62	16,228.26	9,067.29	7,052.44	18,546.26
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Sinopharm Group Co 브루토마진	Sinopharm Group Co 이익 마진	Sinopharm Group Co EBIT-마진	Sinopharm Group Co 이익 마진
2028e	8.13 %	4.18 %	0.52 %
2027e	8.13 %	4.03 %	0.5 %
2026e	8.13 %	3.54 %	0.62 %
2025e	8.13 %	3.5 %	0.61 %
2024e	8.13 %	3.47 %	0.6 %
2023	8.13 %	3.73 %	1.52 %
2022	8.59 %	4.08 %	1.54 %
2021	8.45 %	4 %	1.49 %
2020	8.83 %	4.17 %	1.57 %
2019	8.83 %	4.25 %	1.47 %
2018	9.06 %	4.57 %	1.69 %
2017	8.45 %	4.26 %	1.81 %
2016	8 %	3.95 %	1.8 %
2015	8.19 %	4.04 %	1.65 %
2014	8.16 %	3.93 %	1.44 %
2013	8.02 %	3.66 %	1.35 %
2012	8.06 %	3.58 %	1.45 %
2011	8.17 %	3.56 %	1.53 %
2010	8.43 %	3.48 %	1.75 %
2009	8.05 %	3.29 %	1.8 %
2008	7.95 %	3.07 %	1.53 %
2007	8.2 %	2.54 %	1.22 %
2006	8.38 %	2.02 %	0.43 %

	브루토마진	EBIT-마진	이익 마진
2006	8.38 %	2.02 %	0.43 %
2007	8.2 %	2.54 %	1.22 %
2008	7.95 %	3.07 %	1.53 %
2009	8.05 %	3.29 %	1.8 %
2010	8.43 %	3.48 %	1.75 %
2011	8.17 %	3.56 %	1.53 %
2012	8.06 %	3.58 %	1.45 %
2013	8.02 %	3.66 %	1.35 %
2014	8.16 %	3.93 %	1.44 %
2015	8.19 %	4.04 %	1.65 %
2016	8 %	3.95 %	1.8 %
2017	8.45 %	4.26 %	1.81 %
2018	9.06 %	4.57 %	1.69 %
2019	8.83 %	4.25 %	1.47 %
2020	8.83 %	4.17 %	1.57 %
2021	8.45 %	4 %	1.49 %
2022	8.59 %	4.08 %	1.54 %
2023	8.13 %	3.73 %	1.52 %
2024e	8.13 %	3.47 %	0.6 %
2025e	8.13 %	3.5 %	0.61 %
2026e	8.13 %	3.54 %	0.62 %
2027e	8.13 %	4.03 %	0.5 %
2028e	8.13 %	4.18 %	0.52 %

날짜	Sinopharm Group Co 주당 매출	Sinopharm Group Co EBIT 당 주식	Sinopharm Group Co 주당 이익
2028e	561.41 undefined	0 undefined	2.91 undefined
2027e	543.8 undefined	0 undefined	2.72 undefined
2026e	518.58 undefined	0 undefined	3.22 undefined
2025e	486.65 undefined	0 undefined	2.98 undefined
2024e	457.33 undefined	0 undefined	2.74 undefined
2023	191.17 undefined	7.14 undefined	2.9 undefined
2022	176.93 undefined	7.22 undefined	2.73 undefined
2021	166.97 undefined	6.68 undefined	2.49 undefined
2020	146.7 undefined	6.12 undefined	2.31 undefined
2019	143.21 undefined	6.09 undefined	2.11 undefined
2018	115.94 undefined	5.3 undefined	1.96 undefined
2017	103.76 undefined	4.42 undefined	1.88 undefined
2016	93.38 undefined	3.69 undefined	1.68 undefined
2015	82.64 undefined	3.33 undefined	1.36 undefined
2014	77.41 undefined	3.04 undefined	1.11 undefined
2013	66.14 undefined	2.42 undefined	0.89 undefined
2012	56.51 undefined	2.02 undefined	0.82 undefined
2011	43.39 undefined	1.54 undefined	0.66 undefined
2010	30.57 undefined	1.06 undefined	0.53 undefined
2009	26.01 undefined	0.86 undefined	0.47 undefined
2008	23.33 undefined	0.72 undefined	0.36 undefined
2007	19 undefined	0.48 undefined	0.23 undefined
2006	14.5 undefined	0.29 undefined	0.06 undefined

	주당 매출	EBIT 당 주식	주당 이익
2006	14.5 CNY	0.29 CNY	0.06 CNY
2007	19 CNY	0.48 CNY	0.23 CNY
2008	23.33 CNY	0.72 CNY	0.36 CNY
2009	26.01 CNY	0.86 CNY	0.47 CNY
2010	30.57 CNY	1.06 CNY	0.53 CNY
2011	43.39 CNY	1.54 CNY	0.66 CNY
2012	56.51 CNY	2.02 CNY	0.82 CNY
2013	66.14 CNY	2.42 CNY	0.89 CNY
2014	77.41 CNY	3.04 CNY	1.11 CNY
2015	82.64 CNY	3.33 CNY	1.36 CNY
2016	93.38 CNY	3.69 CNY	1.68 CNY
2017	103.76 CNY	4.42 CNY	1.88 CNY
2018	115.94 CNY	5.3 CNY	1.96 CNY
2019	143.21 CNY	6.09 CNY	2.11 CNY
2020	146.7 CNY	6.12 CNY	2.31 CNY
2021	166.97 CNY	6.68 CNY	2.49 CNY
2022	176.93 CNY	7.22 CNY	2.73 CNY
2023	191.17 CNY	7.14 CNY	2.9 CNY
2024e	457.33 CNY	0 CNY	2.74 CNY
2025e	486.65 CNY	0 CNY	2.98 CNY
2026e	518.58 CNY	0 CNY	3.22 CNY
2027e	543.8 CNY	0 CNY	2.72 CNY
2028e	561.41 CNY	0 CNY	2.91 CNY

	주식 수량
2006	1.64 조. Aktien
2007	1.64 조. Aktien
2008	1.64 조. Aktien
2009	1.81 조. Aktien
2010	2.27 조. Aktien
2011	2.36 조. Aktien
2012	2.4 조. Aktien
2013	2.52 조. Aktien
2014	2.59 조. Aktien
2015	2.77 조. Aktien
2016	2.77 조. Aktien
2017	2.97 조. Aktien
2018	2.97 조. Aktien
2019	2.97 조. Aktien
2020	3.11 조. Aktien
2021	3.12 조. Aktien
2022	3.12 조. Aktien
2023	3.12 조. Aktien
2024e	3.12 조. Aktien
2025e	3.12 조. Aktien
2026e	3.12 조. Aktien
2027e	3.12 조. Aktien
2028e	3.12 조. Aktien

날짜	Sinopharm Group Co 배당금
2028e	0.98 undefined
2027e	0.98 undefined
2026e	0.98 undefined
2025e	0.98 undefined
2024e	0.98 undefined
2023	0.9 undefined
2022	0.87 undefined
2021	0.84 undefined
2020	0.65 undefined
2019	0.67 undefined
2018	0.69 undefined
2017	0.57 undefined
2016	0.48 undefined
2015	0.31 undefined
2014	0.26 undefined
2013	0.25 undefined
2012	0.19 undefined
2011	0.16 undefined
2010	0.01 undefined

	배당금	배당금 (추정)
2006	0 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0.01 CNY	0 CNY
2011	0.16 CNY	0 CNY
2012	0.19 CNY	0 CNY
2013	0.25 CNY	0 CNY
2014	0.26 CNY	0 CNY
2015	0.31 CNY	0 CNY
2016	0.48 CNY	0 CNY
2017	0.57 CNY	0 CNY
2018	0.69 CNY	0 CNY
2019	0.67 CNY	0 CNY
2020	0.65 CNY	0 CNY
2021	0.84 CNY	0 CNY
2022	0.87 CNY	0 CNY
2023	0.9 CNY	0 CNY
2024e	0 CNY	0.98 CNY
2025e	0 CNY	0.98 CNY
2026e	0 CNY	0.98 CNY
2027e	0 CNY	0.98 CNY
2028e	0 CNY	0.98 CNY

날짜	Sinopharm Group Co 배당률
2028e	31.89 %
2027e	32 %
2026e	31.83 %
2025e	31.85 %
2024e	32.33 %
2023	31.3 %
2022	31.92 %
2021	33.76 %
2020	28.23 %
2019	31.89 %
2018	34.98 %
2017	30.51 %
2016	28.72 %
2015	22.74 %
2014	23.38 %
2013	28.09 %
2012	23.17 %
2011	24.24 %
2010	1.91 %
2009	31.3 %
2008	31.3 %
2007	31.3 %
2006	31.3 %

	배당률
2006	31.3 %
2007	31.3 %
2008	31.3 %
2009	31.3 %
2010	1.91 %
2011	24.24 %
2012	23.17 %
2013	28.09 %
2014	23.38 %
2015	22.74 %
2016	28.72 %
2017	30.51 %
2018	34.98 %
2019	31.89 %
2020	28.23 %
2021	33.76 %
2022	31.92 %
2023	31.3 %
2024e	32.33 %
2025e	31.85 %
2026e	31.83 %
2027e	32 %
2028e	31.89 %

EPS-예상치	EPS-실제	보고 분기
1.41	1.34 (-4.8 %)	2024 Q2
1.54	1.58 (2.58 %)	2023 Q4
1.37	1.32 (-3.42 %)	2023 Q2
1.46	2.55 (74.83 %)	2022 Q4
1.26	0.18 (-85.77 %)	2022 Q2
1.5	1.34 (-10.63 %)	2021 Q4
1.06	1.15 (8.41 %)	2021 Q2
1.4	1.38 (-1.25 %)	2020 Q4
1	0.93 (-6.96 %)	2020 Q2
1.25	1.1 (-12.32 %)	2019 Q4
1.14	1 (-12.47 %)	2019 Q2
1.42	0.99 (-30.19 %)	2018 Q4
0.95	0.97 (2.26 %)	2018 Q2
0.8	0.91 (13.65 %)	2017 Q4
0.95	1 (4.85 %)	2017 Q2
0.78	0.77 (-0.67 %)	2016 Q4
0.81	0.91 (12.93 %)	2016 Q2
0.67	0.67 (-0.48 %)	2015 Q4
0.65	0.69 (5.7 %)	2015 Q2
0.54	0.57 (5.44 %)	2014 Q2
0.44	0.43 (-1.96 %)	2013 Q4
0.47	0.46 (-1.96 %)	2013 Q2
0.39	0.42 (6.95 %)	2012 Q4
0.37	0.32 (-14.51 %)	2011 Q4
0.39	0.34 (-12.05 %)	2011 Q2
0.31	0.25 (-20.43 %)	2010 Q4
0.29	0.28 (-4.34 %)	2010 Q2

%-지분	이름	주식	변경
8.54802 %	Lazard Asset Management, L.L.C.	114,698,209	13,863,175
8.51023 %	Fidelity Management & Research Company LLC	114,191,174	-15,208,564
4.24489 %	JPMorgan Asset Management (Asia Pacific) Limited	56,958,400	510,000
3.14340 %	The Vanguard Group, Inc.	42,178,462	201,600
3.06524 %	BlackRock Institutional Trust Company, N.A.	41,129,749	-2,617,600
2.18356 %	Fidelity Institutional Asset Management	29,299,220	3,679,480
1.86539 %	Dimensional Fund Advisors, L.P.	25,030,000	31,600
1.62846 %	Fidelity Management & Research (Hong Kong) Limited	21,850,899	0
1.59835 %	Bosera Asset Management Co., Ltd.	21,446,800	-77,600
1.59491 %	Hang Seng Investment Management Ltd.	21,400,598	587,393
1.35819 %	BlackRock Asset Management Ireland Limited	18,224,370	873,374
1.26912 %	Fidelity Investments Canada ULC	17,029,200	1,426,000
1.22315 %	Norges Bank Investment Management (NBIM)	16,412,336	-3,396,331
1.12634 %	State Street Global Advisors Asia Ltd.	15,113,378	59,211
1.06586 %	BlackRock Advisors (UK) Limited	14,301,795	314,800
1.04236 %	Swedbank Robur Fonder AB	13,986,463	0
1.03991 %	Value Partners Ltd.	13,953,600	-3,198,800
0.98637 %	JPMorgan Asset Management U.K. Limited	13,235,200	700,000
0.96153 %	JP Morgan Asset Management	12,901,972	833,396
0.84373 %	Geode Capital Management, L.L.C.	11,321,199	0
0.76494 %	Nordea Investment Management AB (Denmark)	10,264,000	-198,400
0.72180 %	JPMorgan Asset Management (Taiwan) Limited	9,685,200	0
0.69083 %	Charles Schwab Investment Management, Inc.	9,269,689	814,874
0.66603 %	California State Teachers Retirement System	8,936,831	808,349
0.65292 %	California Public Employees' Retirement System	8,760,948	-1,167,600
0.58241 %	Florida State Board of Administration	7,814,800	495,200
0.53077 %	State Street Global Advisors (US)	7,121,966	96,588
0.52246 %	China Asset Management Co., Ltd.	7,010,400	1,042,000
0.51545 %	Fidelity Management Trust Company	6,916,355	6,916,355
0.47767 %	BlackRock (Netherlands) B.V.	6,409,461	-1,017,786
0.41884 %	Yinhua Fund Management Co., Ltd.	5,620,000	5,092,000
0.41442 %	Bin Yuan Capital Limited	5,560,753	517,200
0.39165 %	Zhong Ou Asset Management Co., Ltd.	5,255,200	5,255,200
0.37026 %	BlackRock Investment Management (UK) Ltd.	4,968,193	125,947
0.36157 %	Principal Global Investors (Hong Kong) Limited	4,851,600	43,600
0.31781 %	Guotai Asset Management Co., Ltd.	4,264,388	-569,982
0.31513 %	Nordea Funds Oy	4,228,400	0
0.29344 %	Robeco Institutional Asset Management B.V.	3,937,429	-158,135
0.28374 %	Kopernik Global Investors, LLC	3,807,200	0
0.28287 %	Dimensional Fund Advisors, Ltd.	3,795,600	57,200
0.28265 %	APG Asset Management N.V.	3,792,565	-3,134,068
0.27658 %	Research Affiliates, LLC	3,711,200	0
0.26425 %	Z¿rcher Kantonalbank (Asset Management)	3,545,672	-1,663,200
0.24406 %	Allspring Global Investments, LLC	3,274,800	0
0.23148 %	E Fund Management Co. Ltd.	3,106,000	34,800
0.22343 %	American Century Investment Management, Inc.	2,998,000	18,000
0.22125 %	Amundi Asset Management, SAS	2,968,800	-36,400
0.21967 %	Lazard Asset Management Limited	2,947,600	-96,400
0.21303 %	Royal London Asset Management Ltd.	2,858,400	357,600
0.20659 %	UBS Asset Management (UK) Ltd.	2,772,094	52,400
0.19391 %	China Asset Management (Hong Kong) Limited	2,601,955	-488,673
0.18945 %	China Merchants Fund Management Co. Ltd.	2,542,000	827,200
0.17398 %	Aviva Investors Global Services Limited	2,334,485	-1,287
0.17265 %	State Street Global Advisors Ireland Limited	2,316,653	-12,400
0.16568 %	BlackRock (Singapore) Limited	2,223,055	-24,888
0.16098 %	Eastspring Investments (Singapore) Limited	2,160,000	0
0.15430 %	China Southern Asset Management Co. Ltd.	2,070,400	1,120,700
0.15367 %	PGGM Vermogensbeheer B.V.	2,061,983	-103,349
0.15296 %	Causeway Capital Management LLC	2,052,400	221,200
0.14801 %	UBS Fund Management (Switzerland) AG	1,986,000	-19,600
0.14674 %	Nuveen LLC	1,968,987	82,000
0.14586 %	JPMorgan Asset Management (China) Company Limited.	1,957,200	1,737,600
0.14160 %	OrbiMed Advisors, LLC	1,900,000	682,300
0.14136 %	ICBC Credit Suisse Asset Management Co. Ltd.	1,896,800	1,896,800
0.13892 %	Bessemer Trust Company, N.A. (US)	1,864,000	0
0.13881 %	State Street Global Advisors (UK) Ltd.	1,862,572	28,400
0.13528 %	MFS Investment Management	1,815,200	2,400
0.12782 %	Northern Trust Global Investments Limited	1,715,035	-35,200
0.12505 %	Storebrand Kapitalforvaltning AS	1,678,000	0
0.12015 %	DWS Investment GmbH	1,612,141	-34,841
0.11911 %	Wellington Management Company, LLP	1,598,287	-2,567
0.11546 %	Penghua Fund Management Co., Ltd.	1,549,200	122,400
0.10822 %	DWS Investments UK Limited	1,452,164	-13,505
0.10780 %	Lazard Frères Gestion S.A.S.	1,446,538	242,800
0.10082 %	UBS Asset Management (Switzerland)	1,352,800	0
0.08930 %	HSBC Global Asset Management (UK) Limited	1,198,184	9,843
0.08913 %	Dodge & Cox	1,196,000	0
0.08866 %	Bellevue Asset Management AG	1,189,600	0
0.08705 %	Matthews International Capital Management, L.L.C.	1,168,000	-1,600
0.08591 %	Amundi Japan Ltd.	1,152,800	0
0.08175 %	Union Investment Luxembourg S.A.	1,096,939	0
0.07906 %	Fullgoal Fund Management Co., Ltd.	1,060,800	-1,719,600
0.07500 %	Nykredit Bank AS	1,006,401	64,000
0.07453 %	Bank of Singapore Limited	1,000,000	0
0.07411 %	EARNEST Partners, LLC	994,400	98,000
0.07274 %	INVESCO Great Wall Fund Management Co. Ltd.	976,000	966,400
0.07269 %	Pictet Asset Management Ltd.	975,400	0
0.07143 %	Caisse de Depot et Placement du Quebec	958,502	698,879
0.06919 %	abrdn Alternative Investments Limited	928,400	0
0.06782 %	BOCI-Prudential Asset Management Ltd.	910,000	0
0.06761 %	Tianhong Asset Management Co., Ltd.	907,200	-1,015,200
0.06707 %	Lion Global Investors Limited	900,000	-300,000
0.06582 %	Mercer Global Investments Management Ltd	883,200	0
0.06514 %	Grantham Mayo Van Otterloo & Co LLC	874,048	-115,600
0.06484 %	Asia Growth Capital Management AB	870,000	-240,000
0.05911 %	Polunin Capital Partners Limited	793,200	-165,600
0.05851 %	CIBC Asset Management Inc.	785,075	0
0.05800 %	First Trust Advisors L.P.	778,294	-326
0.05440 %	UBS Asset Management (Americas), Inc.	730,000	7,600
0.05408 %	ID-Sparinvest A/S	725,600	160,800

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Metsa Board B	공급업체고객	0,93	0,43	-0,34	0,13	0,06	0,27
Basler	공급업체고객	0,55	-0,17	0,20	-0,54	-0,34	0,12
Zhejiang Jiuzhou Pharm A	공급업체고객	0,54	0,37	-0,44	-0,59	-0,46	0,06
China National Medicines A	공급업체고객	0,50	0,40	0,16	-0,18	0,75	-0,12
SciClone Pharmaceuticals	공급업체고객	0,45	0,53	0,17	-0,09	0,89
Shanghai Fosun Pharm H	공급업체고객	0,36	0,59	-0,15	-0,12	0,79	0,70
BeiGene	공급업체고객	0,23	0,43	0,72	-0,18	0,49	0,35
Shanxi Zhendong A	공급업체고객	0,20	0,46	-0,55	0,01	-0,50	-0,22
Oramed Pharmaceuticals	공급업체고객	-0,20	0,43	0,64	-0,16	0,09	0,24
China National Accord A	공급업체고객	-0,25	0,22	0,53	0,11	0,80	-0,01

What values and corporate philosophy does Sinopharm Group Co represent?

Sinopharm Group Co Ltd represents the values of integrity, innovation, and excellence. The company is guided by a corporate philosophy that prioritizes customer-centricity and social responsibility. With a focus on healthcare, Sinopharm Group Co Ltd strives to provide high-quality medical products and services to people worldwide. Through continuous research and development, they aim to improve healthcare access and enhance well-being. By upholding its values and corporate philosophy, Sinopharm Group Co Ltd actively contributes to the advancement of the global healthcare industry, making a positive impact on people's lives.

In which countries and regions is Sinopharm Group Co primarily present?

Sinopharm Group Co Ltd is primarily present in China.

What significant milestones has the company Sinopharm Group Co achieved?

Sinopharm Group Co Ltd has achieved several significant milestones throughout its history. One notable accomplishment is the company's successful listing on the Hong Kong stock exchange in 2009, followed by its inclusion in the Hang Seng Index in 2011. Sinopharm has also made significant advancements in the healthcare industry, expanding its portfolio through acquisitions and strategic collaborations. Notably, the company established Sinopharm Holding Guoda Drugstore, an integrated pharmaceutical retailer. In addition, Sinopharm is at the forefront of medical research and development, collaborating with international pharmaceutical companies and contributing to the innovation of new drugs. Sinopharm Group Co Ltd continues to strive for excellence and cement its position as a leading global healthcare company.

What is the history and background of the company Sinopharm Group Co?

Sinopharm Group Co Ltd, a renowned pharmaceutical and healthcare company, has a rich history and stellar background. Established in 2003, Sinopharm has emerged as a leading player in the healthcare industry. It operates in various segments, including distribution, retail, manufacturing, research, and more. With headquarters in Beijing, China, Sinopharm has focused on expanding its operations globally, establishing a presence across 150 countries. The company strives to improve healthcare accessibility and quality by offering a wide range of products and services, including pharmaceuticals, medical devices, and healthcare solutions. Sinopharm Group Co Ltd's commitment to innovation, quality, and professionalism has earned it a strong reputation in the global market.

Who are the main competitors of Sinopharm Group Co in the market?

The main competitors of Sinopharm Group Co Ltd in the market are Shanghai Fosun Pharmaceutical Group Co Ltd, China Resources Pharmaceutical Group Ltd, and CSPC Pharmaceutical Group Ltd.

In which industries is Sinopharm Group Co primarily active?

Sinopharm Group Co Ltd is primarily active in the healthcare industry.

What is the business model of Sinopharm Group Co?

The business model of Sinopharm Group Co Ltd focuses on providing pharmaceutical and healthcare products and services. Sinopharm Group operates through various segments, including Distribution, Retail Pharmacy, Pharmaceutical Manufacturing, and others. As China's largest pharmaceutical distribution and retail company, Sinopharm Group plays a crucial role in the healthcare industry. The company offers a wide range of products, including prescription drugs, over-the-counter medicines, medical devices, and healthcare services. Sinopharm Group aims to enhance the accessibility and affordability of quality healthcare by ensuring the efficient supply chain and expanding its reach across different regions in China.

Sinopharm Group Co 2024의 P/E 비율은 얼마입니까?

Sinopharm Group Co의 P/E 비율은 15.27입니다.

Sinopharm Group Co 2024의 KUV는 얼마입니까?

Sinopharm Group Co의 P/S 비율은 0.09입니다.

Sinopharm Group Co의 AlleAktien 품질 점수는 얼마인가요?

Sinopharm Group Co에 대한 AlleAktien 품질 점수는 9/10입니다.

Sinopharm Group Co 2024의 매출은 얼마인가요?

예상되는 Sinopharm Group Co 매출은 613.65 조. CNY입니다.

Sinopharm Group Co 2024의 이익은 얼마인가요?

예상되는 Sinopharm Group Co 이익은 3.68 조. CNY입니다.

Sinopharm Group Co은 무엇을 하나요?

Sinopharm Group Co Ltd is a leading Chinese company specializing in the manufacturing and marketing of pharmaceutical products, medical devices, vaccines, health products, and services. The company covers a wide range of business areas, including the production of medicines, vaccines, medical devices, and medical services. It focuses on customizing its offerings to meet the needs of end customers, establishing itself as a strong player in the global market. The company's main emphasis is on the production and marketing of pharmaceutical products, including a wide range of medicines and medical devices such as eye drops, cough and cold medicines, vitamins and minerals, painkillers, antibiotics, and cancer therapeutics. Sinopharm Group Co Ltd is also a leading provider of vaccines, producing and distributing a broad range of vaccines including those for Hepatitis B, rabies, measles, mumps, and rubella. Additionally, the company offers health products like dietary supplements, diagnostic devices, and medical accessories. It also develops and manufactures medical devices such as urinary catheters, implants, and stents. In addition to these areas, Sinopharm Group Co Ltd is also involved in other segments of the healthcare industry such as hospital management and medical services. It operates a chain of hospitals and pharmacies in China, providing medical services such as consultations, diagnoses, prevention, and rehabilitation. The company's business model is focused on offering products and services tailored to the needs and demands of customers. It invests in research and development to create innovative and cost-effective products and solutions.

Sinopharm Group Co 배당금은 얼마입니까?

Sinopharm Group Co은(는) 연간 번의 배당을 통해 0.87 CNY의 배당금을 지급합니다.

Sinopharm Group Co이 얼마나 자주 배당을 지급하나요?

Sinopharm Group Co의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Sinopharm Group Co ISIN이 무엇입니까?

Sinopharm Group Co의 ISIN은 CNE100000FN7입니다.

Sinopharm Group Co WKN은 무엇인가요?

Sinopharm Group Co의 WKN은 A0N99U입니다.

Sinopharm Group Co 티커는 무엇인가요?

Sinopharm Group Co의 티커는 1099.HK입니다.

Sinopharm Group Co이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Sinopharm Group Co은(는) 0.9 CNY 의 배당금을 지급했습니다. 이는 약 5 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Sinopharm Group Co은(는) 0.98 CNY의 배당금을 지급할 것으로 예상됩니다.

Sinopharm Group Co의 배당 수익률은 얼마입니까?

Sinopharm Group Co의 현재 배당 수익률은 5 %입니다.

Sinopharm Group Co의 배당금은 언제 지급되나요?

Sinopharm Group Co은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Sinopharm Group Co의 배당금은 얼마나 안전한가요?

Sinopharm Group Co은(는) 지난 19년 동안 매년 배당금을 지급했습니다.

Sinopharm Group Co의 배당금은 얼마입니까?

향후 12개월 동안 0.98 CNY의 배당금이 예상됩니다. 이는 배당수익률 5.44 %에 해당합니다.

Sinopharm Group Co이(가) 속해 있는 섹터는 어디인가요?

Sinopharm Group Co은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Sinopharm Group Co kaufen, um die vorherige Dividende zu erhalten?

Sinopharm Group Co의 마지막 배당금을 0.956 CNY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Sinopharm Group Co의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Sinopharm Group Co의 2023년도 배당금은 얼마였습니까?

2023년에 Sinopharm Group Co는 0.872 CNY를 배당금으로 지급했습니다.

Sinopharm Group Co는 어떤 화폐로 배당금을 지급하나요?

Sinopharm Group Co의 배당금은 CNY에 지급됩니다.

Scope 1 - 직접 방출	52,434.34
스코프 2 - 구매한 에너지로부터의 간접적인 배출	200,670.94
Scope 3 - 가치 창출 체인 내의 간접 배출
총 CO₂ 배출량	253,105.28
CO₂ 감소 전략
석탄 에너지
원자력
동물 실험
펠츠 & 레더
살충제
팜 오일
담배
유전자 변형 생물체
기후 개념
지속 가능한 임업
재활용 규정
환경 친화적인 포장
위험물질
연료 소비량과 효율성
물 사용량 및 효율성

여성 직원 비율	62.18
관리 직위에서의 여성 비율
아시아 직원 비율
아시아 경영진 비율
히스패닉/라티노 직원 비율
히스패닉/라티노 관리 부문 지분
흑인 직원 비율
블랙 매니지먼트 지분
흰색 종업원의 비율
화이트 매니지먼트 지분
성인 콘텐츠
알코올
무기
총기
도박
군사 계약
인권 개념
개인정보 보호 정책
작업 및 건강 보호
카톨릭

환경 보고
이해관계자 참여
콜백 정책
카르텔법

증권거래소	Sinopharm Group Co 티커
뒤셀도르프	X2S.DU
프랑크푸르트	X2S.F
HKSE	1099.HK
뮌헨	X2S.MU
PNK	SHTDF

Sinopharm Group Co 티커	Sinopharm Group Co FIGI
X2S:TH	BBG000DNDW63
1099:HK	BBG000VWV3Z5
X2S:GR	BBG000VZC4Y8
X2S:GF	BBG000VZC5B0
X2S:GD	BBG000VZC5G5
X2S:GS	BBG000VZC5T1
X2S:GM	BBG000VZC619
X2S:GB	BBG000VZC673
SHTDF:US	BBG000W3LVW0
SHTDF:PQ	BBG000W3LY63
SHTDF:UV	BBG000W3LYT8
1099:H1	BBG006Z3JRY4
X2S:QT	BBG008VHZWG4
1099EUR:EO	BBG008VJH962
1099EUR:XH	BBG008VJH9C5
1099EUR:XF	BBG008VJH9H0
1099EUR:XE	BBG008VJH9L5
1099EUR:XJ	BBG008VJH9N3
1099EUR:XL	BBG008VJH9Q0
1099EUR:XG	BBG008VJH9R9
1099EUR:XO	BBG008VJH9T7
1099EUR:XS	BBG008VJHB12
1099EUR:XA	BBG008VJHB30
1099EUR:E1	BBG008VJHB58
1099EUR:XT	BBG008VJHB76
1099EUR:XW	BBG008VJHB85
1099EUR:XU	BBG008VJHBB1
1099EUR:XV	BBG008VJHBF7
1099EUR:EU	BBG008VJHCZ3
1099:H2	BBG00F1359F7
X2S:GZ	BBG00FGWJSV2
1099EUR:XX	BBG00JN8DSP2
1099N:PO	BBG00JRFW6Q8
1099N:S2	BBG00JRFYN43
1099N:L3	BBG00JRG1G51
1099N:B3	BBG00JRG4LG5
1099HKD:X2	BBG00JRGGWW0
1099HKD:XB	BBG00JRGGWX9
1099HKD:XH	BBG00JRGGWZ7
1099HKD:XF	BBG00JRGGX12
1099HKD:XE	BBG00JRGGX30
1099HKD:XJ	BBG00JRGGX49
1099HKD:XL	BBG00JRGGX58
1099HKD:XG	BBG00JRGGX67
1099HKD:XO	BBG00JRGGX76
1099HKD:XS	BBG00JRGGXC0
1099HKD:XA	BBG00JRGGXD9
1099HKD:E1	BBG00JRGGXF7
1099HKD:XT	BBG00JRGGXG6
1099HKD:XW	BBG00JRGGXH5
1099HKD:XU	BBG00JRGGXJ3
1099HKD:XV	BBG00JRGGXK1
1099HKD:XM	BBG00JRGGXL0
1099HKD:XQ	BBG00JRGGXN8
1099HKD:XX	BBG00JRGGXP6
1099HKD:XZ	BBG00JRGGXQ5
1099HKD:EU	BBG00JRGGXS3
1099N:L1	BBG00Y7B0RH5
X2S:LA	BBG018H91H77
X2S:LU	BBG018J2PJ34

2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e
23.74	31.11	38.19	47.05	69.23	102.23	135.79	166.87	200.13	228.67	258.39	308.35	344.53	425.27	456.42	521.05	552.15	596.57	613.65	653	695.84	729.68	753.31
-	31.06	22.75	23.20	47.16	47.65	32.83	22.89	19.94	14.26	12.99	19.34	11.73	23.44	7.32	14.16	5.97	8.05	2.86	6.41	6.56	4.86	3.24
8.38	8.20	7.95	8.05	8.43	8.17	8.06	8.02	8.16	8.19	8.00	8.45	9.06	8.83	8.83	8.45	8.59	8.13	-	-	-	-	-
1.99	2.55	3.04	3.79	5.84	8.36	10.94	13.38	16.33	18.72	20.67	26.05	31.23	37.53	40.32	44.05	47.43	48.51	0	0	0	0	0
0.48	0.79	1.17	1.55	2.41	3.64	4.86	6.1	7.86	9.23	10.21	13.14	15.75	18.09	19.03	20.84	22.54	22.28	21.29	22.89	24.62	29.39	31.48
2.02	2.54	3.07	3.29	3.48	3.56	3.58	3.66	3.93	4.04	3.95	4.26	4.57	4.25	4.17	4.00	4.08	3.73	3.47	3.50	3.54	4.03	4.18
0.1	0.38	0.59	0.85	1.21	1.56	1.97	2.25	2.87	3.77	4.65	5.58	5.84	6.25	7.19	7.76	8.53	9.05	3.68	4	4.33	3.65	3.91
-	277.23	53.81	44.37	42.91	29.11	26.46	13.98	27.73	31.25	23.20	19.97	4.66	7.13	14.97	7.94	9.89	6.19	-59.38	8.68	8.26	-15.70	7.13
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
1.64	1.64	1.64	1.81	2.27	2.36	2.4	2.52	2.59	2.77	2.77	2.97	2.97	2.97	3.11	3.12	3.12	3.12	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

한 눈에 저평가된 주식을 인식하세요

가격

가격

티커1099.HK

ISINCNE100000FN7

WKNA0N99U

Sinopharm Group Co 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Sinopharm Group Co 주가 이력

Sinopharm Group Co 주식 매출, EBIT, 이익 CNE100000FN7 · A0N99U

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Sinopharm Group Co 매출, 이익 및 EBIT 역사

Sinopharm Group Co 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Sinopharm Group Co 주식 마진 CNE100000FN7 · A0N99U

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Sinopharm Group Co 마진 역사

Sinopharm Group Co 주식 매출, EBIT, 주당 순이익 CNE100000FN7 · A0N99U

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Sinopharm Group Co 매출, 이익 및 EBIT 주당 역사

Sinopharm Group Co 주식 및 주식 분석

Sinopharm Group Co Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Sinopharm Group Co 역사적인 P/E, EBIT 및 P/S에 따른 평가

Sinopharm Group Co 주식 수량 CNE100000FN7 · A0N99U

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Sinopharm Group Co 주식 배당금 CNE100000FN7 · A0N99U

배당금

배당금에 대한 개요

해석 및 사용

투자 전략

Sinopharm Group Co 배당금 내역

Sinopharm Group Co 주식 배당률 CNE100000FN7 · A0N99U

배당비율

연간 배당비율이란 무엇인가요?

데이터 해석 방법

투자에 대한 데이터 사용

Sinopharm Group Co 배당금지급률 역사

한눈에 과소평가된 주식을 인식하세요.

티커
1099.HK

ISIN
CNE100000FN7

WKN
A0N99U